Coronavirus: Vulnerable patients treated with Paxlovid find they improve ‘within hours'

Coronavirus: Vulnerable patients treated with Paxlovid find they improve ‘within hours’

With regard to who gets the drugs, they are only being administered to the most vulnerable, with the highest risk of being admitted to hospital or becoming seriously ill. The way the treatment works is by preventing the virus from multiplying in cells; this allows the patient to fight Covid more effectively. Speaking of the procurements Health Secretary Sajid Javid said: “Both of our groundbreaking antivirals – Molupiravir and Paxlovid – are available to those most vulnerable to the virus directly through the NHS, and it’s fantastic to see 32,000 patients reaping the benefits.“For anyone not in this high-risk group, if you’re aged 50 and over or 18 to 49 with an underlying health condition and test positive, you can sign up to the panoramic study to potentially access this treatment too.”